Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Sales | 171 | 35 | -843 | 465 | 378 |
| Cost of Goods | 82 | 23 | N/A | 290 | 286 |
| Gross Profit | 89 | 11 | N/A | 175 | 92 |
| Operating Expenses | 930 | 1,015 | 1,010 | 735 | 701 |
| Operating Income | -841 | -1,003 | -1,277 | -560 | -610 |
| Interest Expense | 127 | 121 | 128 | 45 | N/A |
| Other Income | -255 | 521 | -900 | 0 | 0 |
| Pre-tax Income | -1,223 | -604 | -2,304 | -605 | -610 |
| Net Income Continuous | -1,223 | -604 | -2,304 | -605 | -610 |
| Net Income | $-1,223 | $-604 | $-2,304 | $-605 | $-610 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.07 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.07 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.07 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.07 | -0.02 | -0.02 |
| EBITDA(a) | $-975 | $-265 | $-1,954 | $-405 | $-526 |